162 results
Page 2 of 9
S-4/A
etbgnbv hqc
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-99.1
p35 r5616n2
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
EX-10.1
obz5xsn2sl ls30
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
8-K
vku8w7 6bcmt7tc
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
kcu 6w3csv7e90renf
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
trj9sv
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
yhqct4w gdq8
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
47tm3ohkoal0eqqvrd92
28 Apr 22
Prospectus supplement for primary offering
8:09am